(Q44411320)

2 December 2017

title

Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury (English)

1 reference

2 December 2017

Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury (English)

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Anesthesiology and pain medicine

26 December 2023

main subject

patient

0 references

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

26 December 2023

5

Donat R Spahn

1 reference

2 December 2017

Martin Doelberg

2

1 reference

2 December 2017

Cornelius Jungheinrich

3

1 reference

2 December 2017

Andrea Sauerland

4

1 reference

2 December 2017

Reto Stocker

6

1 reference

2 December 2017

Thomas A. Neff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12707149

26 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://journals.lww.com/anesthesia-analgesia/Fulltext/2003/05000/Repetitive_Large_Dose_Infusion_of_the_Novel.37.aspx

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12707149

https://journals.lww.com/10.1213/01.ANE.0000061582.09963.FD

26 December 2023

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

26 December 2023

published in

Anesthesia & Analgesia

1 reference

2 December 2017

volume

96

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

1453-9, table of contents

1 reference

Management of head trauma.

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care

26 December 2023

2

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.

26 December 2023

3

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.

26 December 2023

4

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

RETRACTED: The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery

26 December 2023

5

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

RETRACTED: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients

26 December 2023

6

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

The effects of hydroxyethyl starches of varying molecular weights on platelet function

26 December 2023

9

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

26 December 2023

10

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.

26 December 2023

11

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

An international view of hydroxyethyl starches

26 December 2023

13

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

26 December 2023

14

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander

26 December 2023

15

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Influence of hydroxyethyl starch on coagulation in patients during the perioperative period

26 December 2023

16

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

26 December 2023

20

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials

26 December 2023

21

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Debate: Albumin administration should not be avoided

26 December 2023

22

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Debate: Albumin administration should be avoided in the critically ill

26 December 2023

23

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials

26 December 2023

24

1 reference

https://api.crossref.org/works/10.1213/01.ANE.0000061582.09963.FD

RETRACTED: Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery

26 December 2023

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/00000539-200108000-00034

Identifiers

1 reference

2 December 2017

1 reference